Healthcare provider profile · identity verified

Macy Susanne Bailey

Nurse Practitioner · COLUMBUS, OH · NPI 1760126700

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Albuterol Sulfate Hfa	Albuterol Sulfate	417	85
Omeprazole	Omeprazole	318	58
Atorvastatin Calcium	Atorvastatin Calcium	251	67
Fluticasone Propionate	Fluticasone Propionate	203	44
Amlodipine Besylate	Amlodipine Besylate	182	51
Lisinopril	Lisinopril	142	31
Metformin Hcl	Metformin Hcl	142	32
Gabapentin	Gabapentin	133	66
Tizanidine Hcl	Tizanidine Hcl	123	45
Potassium Chloride	Potassium Chloride	118	27
Furosemide	Furosemide	116	27
Hydrochlorothiazide	Hydrochlorothiazide	114	32
Trazodone Hcl	Trazodone Hcl	107	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	101	45
Azelastine Hcl	Azelastine Hcl	99	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	96	27
Losartan Potassium	Losartan Potassium	78	30
Farxiga	Dapagliflozin Propanediol	77	16
Westab Plus	Pnv,calcium 72/Iron/Folic Acid	76	18
Meloxicam	Meloxicam	75	16
Ondansetron Hcl	Ondansetron Hcl	75	13
Ibu	Ibuprofen	69	24
Pantoprazole Sodium	Pantoprazole Sodium	65	16
Diclofenac Sodium	Diclofenac Sodium	60	15
Hydroxyzine Hcl	Hydroxyzine Hcl	60	14
Spironolactone	Spironolactone	60	12
Amitriptyline Hcl	Amitriptyline Hcl	57	15
Carvedilol	Carvedilol	57	17
Alcohol Prep Pads	Alcohol Antiseptic Pads	56	16
Ibuprofen	Ibuprofen	54	23
Buspirone Hcl	Buspirone Hcl	52	13
Levothyroxine Sodium	Levothyroxine Sodium	49	13
Sertraline Hcl	Sertraline Hcl	49	12
Famotidine	Famotidine	47	13
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	46	25
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Metoprolol Succinate	Metoprolol Succinate	45	suppressed
Montelukast Sodium	Montelukast Sodium	45	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	15
Lidocaine	Lidocaine	44	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	20
Alcohol Pads	Alcohol Antiseptic Pads	40	12
Allopurinol	Allopurinol	40	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	17
Baclofen	Baclofen	37	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	37	suppressed
Simvastatin	Simvastatin	36	12
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Pregabalin	Pregabalin	34	17
Bupropion Xl	Bupropion Hcl	32	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	32	suppressed
Naproxen	Naproxen	32	14
Topiramate	Topiramate	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Vascepa	Icosapent Ethyl	30	suppressed
Linzess	Linaclotide	29	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	29	suppressed
Jardiance	Empagliflozin	28	suppressed
Lubiprostone	Lubiprostone	28	suppressed
Ondansetron Odt	Ondansetron	28	14
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Mometasone Furoate	Mometasone Furoate	23	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Fluconazole	Fluconazole	17	12
Novolog Flexpen	Insulin Aspart	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Naloxone Hcl	Naloxone Hcl	16	12
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Nystatin	Nystatin	15	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	14	suppressed
Ozempic	Semaglutide	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Eliquis	Apixaban	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Azithromycin	Azithromycin	12	12
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Dapagliflozin	Dapagliflozin Propanediol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Serevent Diskus	Salmeterol Xinafoate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error